Institutional investors purchased a net $3.4 million shares of ASMB during the quarter ended December 2017. This may signal that the smart money is gaining interest in this company as the 77.56% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL IMPACT ADVISORS LLC Bought 31.9 Thousand shares of Assembly Biosciences Inc
APO ASSET MANAGEMENT GMBH Bought 9.2 Thousand shares of Assembly Biosciences Inc